FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 147 filers reported holding FIBROGEN INC in Q4 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $1,155,091 | +13.2% | 61,902 | -2.8% | 0.01% | +11.1% |
Q4 2022 | $1,020,362 | +53.2% | 63,693 | +24.4% | 0.01% | +50.0% |
Q3 2022 | $666,000 | +13.8% | 51,192 | -7.5% | 0.01% | 0.0% |
Q2 2022 | $585,000 | -49.1% | 55,351 | -42.1% | 0.01% | -50.0% |
Q1 2022 | $1,149,000 | -24.1% | 95,585 | -10.9% | 0.01% | -29.4% |
Q4 2021 | $1,513,000 | +30.4% | 107,290 | -5.5% | 0.02% | +54.5% |
Q3 2021 | $1,160,000 | -64.0% | 113,519 | -6.1% | 0.01% | -60.7% |
Q2 2021 | $3,218,000 | -44.0% | 120,841 | -27.1% | 0.03% | -50.0% |
Q1 2021 | $5,750,000 | -5.1% | 165,655 | +1.4% | 0.06% | -17.6% |
Q4 2020 | $6,057,000 | +27.8% | 163,316 | +41.7% | 0.07% | -2.9% |
Q3 2020 | $4,738,000 | -3.8% | 115,231 | -5.2% | 0.07% | +6.1% |
Q2 2020 | $4,927,000 | -10.4% | 121,556 | -23.2% | 0.07% | -22.4% |
Q1 2020 | $5,497,000 | -27.1% | 158,177 | -10.0% | 0.08% | +44.1% |
Q4 2019 | $7,537,000 | +17.6% | 175,722 | +1.4% | 0.06% | +18.0% |
Q3 2019 | $6,410,000 | -21.1% | 173,324 | -3.6% | 0.05% | -16.7% |
Q2 2019 | $8,120,000 | -3.0% | 179,728 | +16.7% | 0.06% | +1.7% |
Q1 2019 | $8,369,000 | -7.9% | 153,985 | -21.6% | 0.06% | -16.9% |
Q4 2018 | $9,089,000 | +0.3% | 196,390 | +31.6% | 0.07% | +20.3% |
Q3 2018 | $9,066,000 | +20.0% | 149,236 | +23.7% | 0.06% | +20.4% |
Q2 2018 | $7,554,000 | +48.6% | 120,666 | +9.7% | 0.05% | +22.5% |
Q1 2018 | $5,082,000 | +18.0% | 109,993 | +21.0% | 0.04% | +33.3% |
Q4 2017 | $4,307,000 | +2.6% | 90,875 | +16.5% | 0.03% | 0.0% |
Q3 2017 | $4,196,000 | +105.8% | 77,994 | +23.5% | 0.03% | +114.3% |
Q2 2017 | $2,039,000 | +52.3% | 63,133 | +16.2% | 0.01% | +55.6% |
Q1 2017 | $1,339,000 | +3.1% | 54,337 | -10.5% | 0.01% | -10.0% |
Q4 2016 | $1,299,000 | -21.6% | 60,696 | -24.2% | 0.01% | -28.6% |
Q3 2016 | $1,657,000 | +15.1% | 80,045 | -8.8% | 0.01% | +7.7% |
Q2 2016 | $1,440,000 | -2.0% | 87,731 | +27.2% | 0.01% | -13.3% |
Q1 2016 | $1,469,000 | -40.3% | 68,978 | -14.6% | 0.02% | -37.5% |
Q4 2015 | $2,462,000 | -87.9% | 80,800 | -12.9% | 0.02% | +14.3% |
Q3 2015 | $20,335,000 | +1370.4% | 92,769 | +57.6% | 0.02% | +75.0% |
Q2 2015 | $1,383,000 | – | 58,847 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vantage Consulting Group Inc | 605,713 | $9,703,522 | 5.73% |
ARMISTICE CAPITAL, LLC | 3,864,000 | $61,901,280 | 1.08% |
Logos Global Management LP | 525,000 | $8,410,500 | 0.98% |
5AM Venture Management, LLC | 225,583 | $3,613,840 | 0.97% |
Intercontinental Wealth Advisors, LLC | 191,300 | $3,064,626 | 0.91% |
BHK Investment Advisors, LLC | 87,550 | $1,402,551 | 0.79% |
Integral Health Asset Management, LLC | 175,000 | $2,803,500 | 0.59% |
Nan Fung Group Holdings Ltd | 34,106 | $546,378 | 0.38% |
Soleus Capital Management, L.P. | 113,463 | $1,817,677 | 0.26% |
Point72 Asset Management, L.P. | 4,781,645 | $76,601,953 | 0.26% |